Exelixis, Inc.
Corprate Bias Ratings
Risk Level:
Summary:
Exelixis, Inc, an American biotechnology company, does not provide viewpoint protections for its employees. However, it has not publicly terminated business relationships based on views or beliefs. Exelixis integrates ESG into all of its business practices and prioritizes diversity in its hiring and leadership composition. However, it does not discriminate against religious organizations in its charitable giving and has not used its corporate funds or lobbying for ideological purposes. For these reasons, Exelixis receives a Lower Risk rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Exelixis integrates ESG into all of its business practices. From its Sustainability page: “This means integrating environmental, social and ethical governance considerations directly into our research and development projects and business operations as we strive to create sustained value for all our stakeholders” (1)(2). The company prioritizes diversity in its hiring and leadership composition (3). However, it has not publicly fired customers, suppliers, or vendors based on political views or religious beliefs (4).
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.
Exelixis does not provide viewpoint protections for its employees (1).
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Exelixis has not used corporate funds to advance ideological causes, organizations, or policies (1).
All links were last accessed and all information was updated on:
November 20, 2023
Company reports are intended for educational use only. Full Disclaimer